Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2000 1
2014 1
2015 1
2016 2
2017 3
2022 1
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Contemporary Management and Clinical Course of Acute Pulmonary Embolism: The COPE Study.
Becattini C, Agnelli G, Maggioni AP, Dentali F, Fabbri A, Enea I, Pomero F, Ruggieri MP, di Lenarda A, Cimini LA, Pepe G, Cozzio S, Lucci D, Gulizia MM; COPE Investigators. Becattini C, et al. Among authors: enea i. Thromb Haemost. 2023 Jun;123(6):613-626. doi: 10.1055/a-2031-3859. Epub 2023 Feb 9. Thromb Haemost. 2023. PMID: 36758612 Free PMC article.
BACKGROUND: New diagnosis, risk stratification, and treatment strategies became recently available for patients with acute pulmonary embolism (PE) leading to changes in clinical practice and potentially influencing short-term patients' outcomes. RESEARCH QUESTION: The COnt …
BACKGROUND: New diagnosis, risk stratification, and treatment strategies became recently available for patients with acute pulmonary embolis …
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2.
Mavromanoli AC, Barco S, Ageno W, Bouvaist H, Brodmann M, Cuccia C, Couturaud F, Dellas C, Dimopoulos K, Duerschmied D, Empen K, Faggiano P, Ferrari E, Galiè N, Galvani M, Ghuysen A, Giannakoulas G, Huisman MV, Jiménez D, Kozak M, Lang IM, Meneveau N, Münzel T, Palazzini M, Petris AO, Piovaccari G, Salvi A, Schellong S, Schmidt KH, Verschuren F, Schmidtmann I, Toenges G, Klok FA, Konstantinides SV; PEITHO-2 Investigators. Mavromanoli AC, et al. Clin Res Cardiol. 2023 Oct;112(10):1372-1381. doi: 10.1007/s00392-022-02138-4. Epub 2022 Dec 21. Clin Res Cardiol. 2023. PMID: 36539534 Free PMC article. Clinical Trial.
Almost one in four patients, however, continued to have evidence of RV dysfunction over the long term....
Almost one in four patients, however, continued to have evidence of RV dysfunction over the long term....
[Anticoagulation therapy during pulmonary embolism follow-up in clinical practice].
Picariello C, Garascia A, Giordana F, Lo Giudice F, Romaniello A, Vedovati MC, Enea I, Caravita S, Camassa N, Vatrano M, Bongarzoni A, Roncon L, Gabrielli D, Colivicchi F. Picariello C, et al. Among authors: enea i. G Ital Cardiol (Rome). 2023 Apr;24(4):275-284. doi: 10.1714/4004.39818. G Ital Cardiol (Rome). 2023. PMID: 36971171 Italian.
In patients with venous thromboembolism (VTE), direct oral anticoagulants (DOACs) are the recommended treatment (class I, level of evidence B in the latest European guidelines), and in most cases, an "extended" or "long-term" low-dose therapy is warranted. This paper aims …
In patients with venous thromboembolism (VTE), direct oral anticoagulants (DOACs) are the recommended treatment (class I, level of evidence …
Fondaparinux in the initial and long-term treatment of venous thromboembolism.
Pesavento R, Amitrano M, Trujillo-Santos J, Di Micco P, Mangiacapra S, López-Jiménez L, Falgá C, García-Bragado F, Piovella C, Prandoni P, Monreal M; RIETE Investigators. Pesavento R, et al. Thromb Res. 2015 Feb;135(2):311-7. doi: 10.1016/j.thromres.2014.11.032. Epub 2014 Dec 13. Thromb Res. 2015. PMID: 25543161
BACKGROUND: Even in the absence of evidence on its long-term efficacy and safety, a number of patients with venous thromboembolism (VTE) receive long-term therapy with fondaparinux alone in everyday practice. ...Among patients with cancer, there were no differences …
BACKGROUND: Even in the absence of evidence on its long-term efficacy and safety, a number of patients with venous thromboembolism (V …
Contemporary anticoagulant treatment strategies in patients with acute pulmonary embolism at different risk for death.
Becattini C, Agnelli G, Diamanti M, Maggioni AP, Vanni S, Dentali F, Enea I, Bortolotti P, De Vecchi M, Artusi N, Picariello C, Nitti C, Lucci D, Gulizia MM; COPE Investigators. Becattini C, et al. Among authors: enea i. Vascul Pharmacol. 2023 Dec;153:107245. doi: 10.1016/j.vph.2023.107245. Epub 2023 Nov 25. Vascul Pharmacol. 2023. PMID: 38013135
INTRODUCTION: Availability of new treatment strategies for patients with acute pulmonary embolism (PE) have changed clinical practice with potential influence in short-term patients' outcomes. We aimed at assessing contemporary anticoagulation strategies and mortality in p …
INTRODUCTION: Availability of new treatment strategies for patients with acute pulmonary embolism (PE) have changed clinical practice with p …
Acute pulmonary embolism and cancer: findings from the COPE study.
Becattini C, Cimini LA, Bassanelli G, Maggioni AP, Pomero F, Lobascio I, Enea I, Pomata DP, Ruggieri MP, Zalunardo B, Novelli A, Di Fusco SA, Triggiani M, Marzolo M, Fioravanti C, Agnelli G, Gonzini L, Gulizia MM; COPE Investigators. Becattini C, et al. Among authors: enea i. Clin Res Cardiol. 2024 Feb;113(2):288-300. doi: 10.1007/s00392-023-02323-z. Epub 2023 Nov 15. Clin Res Cardiol. 2024. PMID: 37966670 Free PMC article.
BACKGROUND: Patients with acute venous thromboembolism associated with cancer have an increased risk of recurrences and bleeding in the long term. RESEARCH QUESTION: To describe the clinical features and short-term course of patients with acute pulmonary embolism (P …
BACKGROUND: Patients with acute venous thromboembolism associated with cancer have an increased risk of recurrences and bleeding in the long …
ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism.
D'Agostino C, Zonzin P, Enea I, Gulizia MM, Ageno W, Agostoni P, Azzarito M, Becattini C, Bongarzoni A, Bux F, Casazza F, Corrieri N, D'Alto M, D'Amato N, D'Armini AM, De Natale MG, Di Minno G, Favretto G, Filippi L, Grazioli V, Palareti G, Pesavento R, Roncon L, Scelsi L, Tufano A. D'Agostino C, et al. Among authors: enea i. Eur Heart J Suppl. 2017 May;19(Suppl D):D309-D332. doi: 10.1093/eurheartj/sux030. Epub 2017 May 2. Eur Heart J Suppl. 2017. PMID: 28751848 Free PMC article.
Knowledge of pathophysiology and therapeutic approaches is fundamental to decide the most appropriate long-term treatment. Moreover, prognostic stratification during the FU should be constantly updated on the basis of the new evidence acquired. ...Novel oral anticoagulants …
Knowledge of pathophysiology and therapeutic approaches is fundamental to decide the most appropriate long-term treatment. Moreover, …
Clinical presentation and in-hospital death in acute pulmonary embolism: does cancer matter?
Casazza F, Becattini C, Rulli E, Pacchetti I, Floriani I, Biancardi M, Scardovi AB, Enea I, Bongarzoni A, Pignataro L, Agnelli G. Casazza F, et al. Among authors: enea i. Intern Emerg Med. 2016 Sep;11(6):817-24. doi: 10.1007/s11739-016-1431-9. Epub 2016 Mar 29. Intern Emerg Med. 2016. PMID: 27023066
Cancer is one of the most common risk factors for acute pulmonary embolism (PE), but only few studies report on the short-term outcome of patients with PE and a history of cancer. The aim of the study was to assess whether a cancer diagnosis affects the clinical presentati …
Cancer is one of the most common risk factors for acute pulmonary embolism (PE), but only few studies report on the short-term outcom …
ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives.
Nardi F, Gulizia MM, Colivicchi F, Abrignani MG, Di Fusco SA, Di Lenarda A, Di Tano G, Geraci G, Moschini L, Riccio C, Verdecchia P, Enea I. Nardi F, et al. Among authors: enea i. Eur Heart J Suppl. 2017 May;19(Suppl D):D70-D88. doi: 10.1093/eurheartj/sux007. Epub 2017 May 2. Eur Heart J Suppl. 2017. PMID: 28751836 Free PMC article.
Special attention is finally paid to the development of clinical algorithms for medium and long-term follow-up of patients treated with new oral direct anticoagulants....
Special attention is finally paid to the development of clinical algorithms for medium and long-term follow-up of patients treated wi …
Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.
Prandoni P, Vedovetto V, Ciammaichella M, Bucherini E, Corradini S, Enea I, Cosmi B, Mumoli N, Visonà A, Barillari G, Bova C, Quintavalla R, Zanatta N, Pedrini S, Villalta S, Camporese G, Testa S, Parisi R, Becattini C, Cuppini S, Pengo V, Palareti G; Morgagni Investigators. Prandoni P, et al. Among authors: enea i. Thromb Res. 2017 Jun;154:35-41. doi: 10.1016/j.thromres.2017.04.002. Epub 2017 Apr 4. Thromb Res. 2017. PMID: 28407492 Clinical Trial.
BACKGROUND: The optimal long-term strategy for preventing recurrent venous thromboembolism (VTE) in patients with deep-vein thrombosis (DVT) is uncertain. ...However, in males with unprovoked DVT there is room for further improving the long-term strategy of VTE prev …
BACKGROUND: The optimal long-term strategy for preventing recurrent venous thromboembolism (VTE) in patients with deep-vein thrombosi …
13 results